SCOPUS 정보 검색 플랫폼

Volumn 7, Issue 2, 2007, Pages 196-198

Mixed-ligand coordination species: A promising approach for "second-generation" drug development

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33847307443 PISSN: 15287483 EISSN: None Source Type: Journal
DOI: 10.1021/cg060602f Document Type: Article

Times cited : (52)

References (32)

1
- 0034563301
- Cini, R. Comments Inorg. Chem, 2000, 22, 151-186.
- (2000) Comments Inorg. Chem , vol.22 , pp. 151-186
- Cini, R.¹

2
- 0003549744
- WELEY-VCH: Weinheim, Germany
- Lippert, B. Cisplatin - Chemistry and Biochemistry of a Leading Anticancer Drug; WELEY-VCH: Weinheim, Germany, 1999.
- (1999) Cisplatin - Chemistry and Biochemistry of a Leading Anticancer Drug
- Lippert, B.¹

3
- 0003445503
- Wiley: New York
- Schmidbaur, H. Gold-Progress in Chemistry, Biochemistry and Technology; Wiley: New York, 1999.
- (1999) Gold-Progress in Chemistry, Biochemistry and Technology
- Schmidbaur, H.¹

4
- 0003983304
- Kluwer: Dordrecht, The Netherlands
- Parrel, N. Transition Metal Complexes as Drugs and Chemotherapeutic Agents; Kluwer: Dordrecht, The Netherlands, 1989.
- (1989) Transition Metal Complexes as Drugs and Chemotherapeutic Agents
- Parrel, N.¹

5
- 84980443110
- Guo, Z.; Sadler, P. J. Angew. Chem., Int. Ed. 1999, 38, 1513-1531.
- (1999) Angew. Chem., Int. Ed , vol.38 , pp. 1513-1531
- Guo, Z.¹ Sadler, P.J.²

6
- 0016916478
- Sorenson, J. R. J. J. Med. Chem. 1976, 19, 135-148.
- (1976) J. Med. Chem , vol.19 , pp. 135-148
- Sorenson, J.R.J.¹

7
- 0010322027
- Kluwer: Dordrecht, The Netherlands
- Milanino, R.; Rainsford, K. D.; Velo, G. P. Copper and Zinc in Inflammation; Kluwer: Dordrecht, The Netherlands, 1989.
- (1989) Copper and Zinc in Inflammation
- Milanino, R.¹ Rainsford, K.D.² Velo, G.P.³

8
- 0036783909
- Weder, J. E.; Dillon, C. T.; Hambley, T. W.; Kennedy, B. J.; Lay, P. A.; Biffin, J. R.; Regtop, H. L.; Davies, N. M. Coord. Chem. Rev. 2002, 232, 95-126.
- (2002) Coord. Chem. Rev , vol.232 , pp. 95-126
- Weder, J.E.¹ Dillon, C.T.² Hambley, T.W.³ Kennedy, B.J.⁴ Lay, P.A.⁵ Biffin, J.R.⁶ Regtop, H.L.⁷ Davies, N.M.⁸

9
- 0031024171
- Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Adv. Drug Delivery Rev. 1997, 23, 3-25.
- (1997) Adv. Drug Delivery Rev , vol.23 , pp. 3-25
- Lipinski, C.A.¹ Lombardo, F.² Dominy, B.W.³ Feeney, P.J.⁴

10
- 0022349214
- Banks, W. A.; Kastin, A. J. Brain Res. Bull. 1985, 15, 287-292.
- (1985) Brain Res. Bull , vol.15 , pp. 287-292
- Banks, W.A.¹ Kastin, A.J.²

11
- 0029871091
- Begley, D. J. J. Pharm. Pharmacol. 1996, 48, 136-146.
- (1996) J. Pharm. Pharmacol , vol.48 , pp. 136-146
- Begley, D.J.¹

12
- 1042264121
- Huang, L. F.; Tong, W. Q. Adv. Drug Delivery Rev. 2004, 56, 321-334.
- (2004) Adv. Drug Delivery Rev , vol.56 , pp. 321-334
- Huang, L.F.¹ Tong, W.Q.²

13
- 33847266007
- Neervannan, S. Am. Pharm. Rev. 2004, 7, 110-113.
- (2004) Am. Pharm. Rev , vol.7 , pp. 110-113
- Neervannan, S.¹

14
- 0003736695
- Wiley: New York
- Lednicer, D. Strategies for Organic Drug Synthesis and Design; Wiley: New York, 1998.
- (1998) Strategies for Organic Drug Synthesis and Design
- Lednicer, D.¹

15
- 0004284003
- Brittain, H. G. Ed, Marcel Dekker, Inc, New York
- Brittain, H. G.; Grant, D. J. W. In Polymorphism in Pharmaceutical Solids; Brittain, H. G. Ed.; Marcel Dekker, Inc.: New York, 1999; pp 279-330.
- (1999) Polymorphism in Pharmaceutical Solids , pp. 279-330
- Brittain, H.G.¹ Grant, D.J.W.²

16
- 33847301681
- Yu, A. M.; Idle, J. R.; Gonzalez, F. J. Drug. Metab. Rev. 2004, 36, 234-277.
- (2004) Drug. Metab. Rev , vol.36 , pp. 234-277
- Yu, A.M.¹ Idle, J.R.² Gonzalez, F.J.³

17
- 1042287178
- Raw, A. S.; Furness, M. S.; Gill, D. S.; Adams, R. C.; Holcombe, F. O.; Yu, L. X. Adv. Drug Delivery Rev. 2004, 56, 397-414.
- (2004) Adv. Drug Delivery Rev , vol.56 , pp. 397-414
- Raw, A.S.¹ Furness, M.S.² Gill, D.S.³ Adams, R.C.⁴ Holcombe, F.O.⁵ Yu, L.X.⁶

18
- 0000382986
- Desiraju, G. R. Curr. Opin. Solid State Mater. Sci. 1997, 2, 451-454.
- (1997) Curr. Opin. Solid State Mater. Sci , vol.2 , pp. 451-454
- Desiraju, G.R.¹

19
- 5044235632
- Almarsson, O.; Zaworotko, M. J. Chem. Commun. 2004, 1889-1896.
- (2004) Chem. Commun , pp. 1889-1896
- Almarsson, O.¹ Zaworotko, M.J.²

20
- 19944371772
- Trask, A. V.; Motherwell, W. D. S.; Jones, W. Cryst. Growth Des. 2005, 5, 1013-1021.
- (2005) Cryst. Growth Des , vol.5 , pp. 1013-1021
- Trask, A.V.¹ Motherwell, W.D.S.² Jones, W.³

21
- 33645036399
- Reddy, L. S.; Babu, N. J.; Nangia, A. Chem. Commun. 2006, 1369-1371.
- (2006) Chem. Commun , pp. 1369-1371
- Reddy, L.S.¹ Babu, N.J.² Nangia, A.³

22
- 33847284217
- Crystal data: For complex 3, C46H36Br 2Cu2N2O16, M, 1159.67, triclinic, P1̄, a, 9.3687(19) Å. b, 10.792(2) Å, c, 12.266(3) Å. α, 71.44(3)°, β= 74.33(3)°, γ, 83.52(3)°, V, 1131.5(4) Å3, Z, 1, μ(Mo Kα, 2.781 mm-1, T= 90(2) K, R1, 0.1026, wR2, 0.2477. The crystal of complex 3 was determined to be nonmerohedral twins, and detwinned diffraction data were used to refine the structure. For complex 4, C66H44Cl2Cu 2N2O20, M, 1383.01, triclinic, P1̄, a, 10.423(18) Å, b, 11.032(18) Å, c, 14.32(2) Å, α, 104.03(3)°, β, 94.41(3)°, γ, 108.91(4)°, γ, 1490(4) Å3, Z, 1, μ(Mo Kα, 0.886 mm-1, T, 90(2) K, R1, 0.1312, wR2, 0.3271. The crystal of complex 4 is crisp and the
- -1, T = 90(2) K, R1 = 0.0587, wR2 = 0.1331.

23
- 0020599769
- Yalkowsky, S. H.; Valvani, S. C.; Roseman, T. J. J. Pharm. Sci. 1983, 72, 866-870.
- (1983) J. Pharm. Sci , vol.72 , pp. 866-870
- Yalkowsky, S.H.¹ Valvani, S.C.² Roseman, T.J.³

24
- 0000544123
- Pinsuwan, S.; Li, A.; Yalkowsky, S. H. J. Chem. Eng. Data 1995, 40, 623-626.
- (1995) J. Chem. Eng. Data , vol.40 , pp. 623-626
- Pinsuwan, S.¹ Li, A.² Yalkowsky, S.H.³

25
- 0344835855
- Jozan, M.; Takacs-Novak, K. Int. J. Pharm. 1997, 159, 233-242.
- (1997) Int. J. Pharm , vol.159 , pp. 233-242
- Jozan, M.¹ Takacs-Novak, K.²

26
- 33749000228
- Fujita, T.; Iwasa, J.; Hansch, C. J. Am. Chem. Soc. 1964, 86, 5175-5180.
- (1964) J. Am. Chem. Soc , vol.86 , pp. 5175-5180
- Fujita, T.¹ Iwasa, J.² Hansch, C.³

27
- 8644243613
- Leo, A.; Hansch, C.; Elkins, D. Chem. Rev. 1971, 71, 525-616.
- (1971) Chem. Rev , vol.71 , pp. 525-616
- Leo, A.¹ Hansch, C.² Elkins, D.³

28
- 33847262216
- Academic Press: London, Chapter 2, pp
- Silverman, R. B. The Organic Chemistry of Drug Design and Drug Action; Academic Press: London, 1992; Chapter 2, pp 30-31.
- (1992) The Organic Chemistry of Drug Design and Drug Action , pp. 30-31
- Silverman, R.B.¹

29
- 14844317393
- Charton, M.; Charton, B. I. Collect. Czech. Chem. Commun. 2004, 69, 2147-2173.
- (2004) Collect. Czech. Chem. Commun , vol.69 , pp. 2147-2173
- Charton, M.¹ Charton, B.I.²

30
- 0003767299
- Elsevier: Amsterdam
- Desiraju, G. R. Crystal Engineering: The Design of Organic Solids; Elsevier: Amsterdam, 1989.
- (1989) Crystal Engineering: The Design of Organic Solids
- Desiraju, G.R.¹

31
- 0018175839
- Koch, P. A.; Schultz, C. A.; Wills, R. J.; Hallquist, S. L.; Welling, P. G. J. Pharm. Sci. 1978, 67, 1533-1535.
- (1978) J. Pharm. Sci , vol.67 , pp. 1533-1535
- Koch, P.A.¹ Schultz, C.A.² Wills, R.J.³ Hallquist, S.L.⁴ Welling, P.G.⁵

32
- 33847263710
- Calculated log P value for aspirin using Advanced Chemistry Development (ACD/Labs) software, version 8.14, for Solaris
- Calculated log P value for aspirin using Advanced Chemistry Development (ACD/Labs) software, version 8.14, for Solaris.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.